Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection
Korean J Hepatol. 2008;14(3):318-330.   Published online 2008 Sep 30     DOI: https://doi.org/10.3350/kjhep.2008.14.3.318
Citations to this article as recorded by Crossref logo
Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C
Baek Gyu Jun, Eui Ju Park, Woong Cheul Lee, Jae Young Jang, Soung Won Jeong, Young Don Kim, Gab Jin Cheon, Young Sin Cho, Sae Hwan Lee, Hong Soo Kim, Yun Nah Lee, Sang Gyune Kim, Young Seok Kim, Boo Sung Kim
The Korean Journal of Internal Medicine.2019; 34(5): 989.     CrossRef
KASL clinical practice guidelines: management of hepatitis C
Clinical and Molecular Hepatology.2016; 22(1): 76.     CrossRef
Efficacy and safety of pegylated interferon base treatment in patients with chronic hepatitis C on dialysis
Sang Bong Ahn, Dae Won Jun, Sang Gyune Kim, Sae Hwan Lee, Hyun Phil Shin, Won Hyeok Choe, Ja Kyung Kim, Kyu Sik Jung, Do Young Kim, Jae-Jun Shim, Soo Young Park, Yeon Seok Seo, Won Kim, Jae Il Chung
European Journal of Internal Medicine.2015; 26(4): 292.     CrossRef
Phylogeny and molecular evolution of the hepatitis C virus
Paulina Jackowiak, Karolina Kuls, Lucyna Budzko, Anna Mania, Magdalena Figlerowicz, Marek Figlerowicz
Infection, Genetics and Evolution.2014; 21: 67.     CrossRef
KASL clinical practice guidelines: Management of Hepatitis C
Clinical and Molecular Hepatology.2014; 20(2): 89.     CrossRef
Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients
Hyun Seok Lee, Young Oh Kweon, Won Young Tak, Soo Young Park, Eun Jung Kang, Yu Lim Lee, Hae Min Yang, Hyun Woo Park
Clinical and Molecular Hepatology.2013; 19(2): 148.     CrossRef
Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
Young Kul Jung, Ju Hyun Kim
Clinical and Molecular Hepatology.2013; 19(1): 26.     CrossRef
Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C
Seok Hoo Jeong, Young Kul Jung, Jae Won Yang, Sang Jin Park, Jong Woo Kim, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim
Clinical and Molecular Hepatology.2012; 18(4): 360.     CrossRef
Efficacy and Tolerability of Peginterferon Alpha Plus Ribavirin in the Routine Daily Treatment of Chronic Hepatitis C Patients in Korea: A Multi-Center, Retrospective Observational Study
Sang Hoon Park, Choong Kee Park, Jin Woo Lee, Young Seok Kim, Sook-Hyang Jeong, Yun Soo im, Ju Hyun Kim, Seong Gyu Hwang, Kyu Sung Rim, Hyung Joon Yim, Jae Youn Cheong, Sung Won Cho, June Sung Lee, Young Min Park, Jeong Won Jang Chun Kyon Lee, Joo Hyun Sh
Gut and Liver.2012; 6(1): 98.     CrossRef
Efficacy of Peginterferon and Ribavirin Combination Therapy of Chronic Hepatitis C: A Pooled Analysis
Soo Yong Park, Min Young Rim, In Ku Yo, Min Su Ha, Ju Seung Kim, Ji Won Lee, Young Kul Jung, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim
The Korean Journal of Gastroenterology.2012; 60(5): 306.     CrossRef
A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
Byung Chul You, Young Seok Kim, Hun il Kim, Se Hun Kim, Seung Sik Park, Yu Ri Seo, Sang Gyune Kim, Se Whan Lee, Hong Soo Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim
Clinical and Molecular Hepatology.2012; 18(3): 272.     CrossRef
A Case of Interstitial Pneumonitis and Pancytopenia Following the Combination Therapy of Pegylated Interferon and Ribavirin
Ji-Hyun Suh, Sung Hwahn Hahn, Ji Eun Lee, Jin Hyung Han, Kyung-Mook Kim, Doh-Hyung Kim, Yon-Seop Kim, Jae-Suk Park, Young-Koo Jee
Tuberculosis and Respiratory Diseases.2011; 70(1): 69.     CrossRef
Role of vitamin D in chronic hepatitis C
Tae Yeob Kim
The Korean Journal of Hepatology.2011; 17(2): 170.     CrossRef
Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
Yu Jin Kim, Jin Woo Lee, Yun Soo Kim, Sook-Hyang Jeong, Young Seok Kim, Hyung Joon Yim, Bo Hyun Kim, Chun Kyon Lee, Choong Kee Park, Sang Hoon Park
The Korean Journal of Hepatology.2011; 17(3): 199.     CrossRef
24 Weeks Treatment with Pegylated Interferon Alfa Plus Ribavirin May Be Possible in Genotype 1 Chronic Hepatitis C Patients with Rapid Virological Response Who Have Low Pretreatment Viremia
Sung Soo Moon, Hyoun Gu Kang, Jeong Ah Seo, Eun Uk Jung, Sang Heon Lee, Sung Jae Park, Youn Jae Lee, Sang Yong Seol
The Korean Journal of Gastroenterology.2010; 56(1): 33.     CrossRef
Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response
Soung Won Jeong, Jin Dong Kim, Hyun Young Woo, Chan Ran You, Sung Won Lee, Myeong Jun Song, Jung Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
The Korean Journal of Hepatology.2009; 15(3): 338.     CrossRef
Current status of liver disease in Korea: Hepatitis C
Young-Suk Lim
The Korean Journal of Hepatology.2009; 15(Suppl 6): S25.     CrossRef
Treatment of chronic hepatitis C: Efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients
Youn Jae Lee
The Korean Journal of Hepatology.2008; 14(4): 443.     CrossRef